Chylothorax is a rare condition caused by damage to the thoracic duct, leading to chyle from the lymphatic system leaking into the pleural cavity. The diagnosis is based on triglyceride and cholesterol levels in the pleural fluid. Various imaging methods, including computed tomography scans and lymphatic-specific investigations, may be utilized to identify the site of a chyle leak. The management of chylothorax requires a multidisciplinary approach employing conventional therapy and possibly thoraco-surgical intervention for patients who do not respond to standard treatment. Complications include malnutrition, immunosuppression, and respiratory distress. We present the case of a 57-year-old female patient who presented with chylothorax after an apparently minor car accident, illustrating problems with delayed recognition of trauma and difficulty in localizing the lymphatic leak.
22 September 2026 in International Journal of Innovative Technologies in Social Science
Background: Diffuse idiopathic skeletal hyperostosis (DISH) is a non-inflammatory, chronic, systemic disorder characterized by ossification of entheses, primarily affecting the spine. DISH is mostly asymptomatic but can manifest with chronic pain, limitation of spinal mobility, and rarely dysphagia. Aim: Our aim is to highlight the significance of DISH and its prevalence in the general population, as well as to raise awareness among clinicians of its role in the differential diagnosis of dysphagia, given that few similar cases have been reported and that surgical management is associated with a good prognosis. Description of the case: A 66-year-old male was admitted to the Department of Neurosurgery with a nine-year history of dysphagia and neck stiffness, which worsened over the preceding two years. CT and MRI scans revealed diffuse calcification of the anterior spinal ligament consistent with a diagnosis of DISH. The patient underwent surgical removal of osteophytes at the C4–C5–C6 levels. Postoperatively, the patient showed no neurological deficits, with only mild intermittent swallowing difficulties that considerably improved. Conclusions: DISH should be considered in the differential diagnosis of chronic dysphagia in elderly patients, particularly when associated with cervical pain or reduced neck mobility. Surgical removal of osteophytes may provide substantial symptomatic relief in selected patients with severe or progressive symptoms. Increased awareness of this uncommon presentation may facilitate earlier diagnosis and treatment.
28 September 2026 in International Journal of Innovative Technologies in Social Science
One of the most widespread liver diseases in the world is metabolic dysfunction-associated steatotic liver disease (MASLD), known until recently as non-alcoholic fatty liver disease (NAFLD). Its prevalence is estimated at 25% in the global population. MASLD is defined as a clinical condition characterized by excessive fat accumulation in the liver in the presence of at least one cardiometabolic risk factor. Although obesity plays a significant role in the pathomechanism of MASLD, it is estimated that approximately 10-20% of MASLD cases occur in individuals with a BMI <25 kg/m² (<23 kg/m² in the Asian population). As studies show, individuals with lean MASLD have a higher risk of liver fibrosis and overall mortality. The aim of this study is a critical review of the current literature regarding the Lean MASLD phenotype, with particular emphasis on its metabolic heterogeneity. The work analyzes unique pathophysiological mechanisms, such as genetic predispositions and adipose tissue distribution disorders, and evaluates their impact on the risk of progression to advanced fibrosis and hepatocellular carcinoma. This work constitutes a literature review, focusing on clinical and cohort studies as well as review papers concerning the pathogenesis, diagnostics, and clinical course of liver steatosis in individuals with a normal BMI. The literature analysis indicates a significant role of genetic variants, mainly the PNPLA3 polymorphism (I148M), which predisposes lean individuals to disease progression independently of metabolic factors. It has been shown that despite a normal BMI, these patients are often characterized by visceral adipose tissue dysfunction and an altered gut microbiota profile. Metabolic heterogeneity is manifested by the existence of a subgroup of patients with a "metabolically healthy" profile, in whom cardiovascular risk may be lower, but the risk of progression of liver lesions remains significant. The following work emphasizes that Lean MASLD is not a milder form of liver steatosis, and its diagnostics require going beyond the standard BMI measurement. It is necessary to implement personalized monitoring strategies, taking into account the genetic profile and metabolic assessment, to prevent long-term complications in this specific group of patients.